Correlation Between Dow Jones and Basilea Pharmaceutica
Can any of the company-specific risk be diversified away by investing in both Dow Jones and Basilea Pharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dow Jones and Basilea Pharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dow Jones Industrial and Basilea Pharmaceutica AG, you can compare the effects of market volatilities on Dow Jones and Basilea Pharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dow Jones with a short position of Basilea Pharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dow Jones and Basilea Pharmaceutica.
Diversification Opportunities for Dow Jones and Basilea Pharmaceutica
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dow and Basilea is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Dow Jones Industrial and Basilea Pharmaceutica AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Basilea Pharmaceutica and Dow Jones is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dow Jones Industrial are associated (or correlated) with Basilea Pharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Basilea Pharmaceutica has no effect on the direction of Dow Jones i.e., Dow Jones and Basilea Pharmaceutica go up and down completely randomly.
Pair Corralation between Dow Jones and Basilea Pharmaceutica
Assuming the 90 days trading horizon Dow Jones is expected to generate 2.2 times less return on investment than Basilea Pharmaceutica. But when comparing it to its historical volatility, Dow Jones Industrial is 2.4 times less risky than Basilea Pharmaceutica. It trades about 0.24 of its potential returns per unit of risk. Basilea Pharmaceutica AG is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 4,210 in Basilea Pharmaceutica AG on April 23, 2025 and sell it today you would earn a total of 1,150 from holding Basilea Pharmaceutica AG or generate 27.32% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Dow Jones Industrial vs. Basilea Pharmaceutica AG
Performance |
Timeline |
Dow Jones and Basilea Pharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Dow Jones Industrial
Pair trading matchups for Dow Jones
Basilea Pharmaceutica AG
Pair trading matchups for Basilea Pharmaceutica
Pair Trading with Dow Jones and Basilea Pharmaceutica
The main advantage of trading using opposite Dow Jones and Basilea Pharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dow Jones position performs unexpectedly, Basilea Pharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Basilea Pharmaceutica will offset losses from the drop in Basilea Pharmaceutica's long position.Dow Jones vs. Shenzhen Investment Holdings | Dow Jones vs. WT Offshore | Dow Jones vs. Guangdong Investment Limited | Dow Jones vs. KNOT Offshore Partners |
Basilea Pharmaceutica vs. Santhera Pharmaceuticals Holding | Basilea Pharmaceutica vs. Idorsia | Basilea Pharmaceutica vs. Molecular Partners AG | Basilea Pharmaceutica vs. Evolva Holding SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |